化与溶解葡萄糖作为一种体积替代疗法,用于在急性心力衰竭 (SOLVRED-AHF) 中更有效地缓解血压:一项前性,随机化,机械学研究
Jan Biegus1, Gracjan Iwanek1, Jeffrey Testani2
1Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
European journal of heart failure
|June 2, 2025
概括
在急性心力衰竭中,与葡萄糖相比,盐水 (0.9% NaCl) 输注增强了脱血,增加了尿液输出和尿,同时减少了尿液需求. 这表明盐水有助于通过抑制再吸收来提取液体.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 关键护理医学 关键护理医学
背景情况:
- 传统的急性心力衰竭 (AHF) 解压方法强调/限制.
- 这项研究通过调查同位素输液策略来挑战这种范式.
研究的目的:
- 为了比较5%葡萄糖与0.9%NaCl输液在接受尿剂治疗的AHF患者的脱血效应.
- 评估/补充剂对利尿症,自然利尿症和利尿剂需求的影响.
主要方法:
- 一个单中心,前性,随机,单盲研究,涉及50名患有流体过载的患者.
- 患者接受了连续输注0.9%的NaCl或5%的葡萄糖 (83.3毫升/小时) 48小时,同时进行协议化尿剂治疗.
- 同主终点包括24小时和48小时的尿液输出,48小时的尿和罗塞米德总剂量.
主要成果:
- 与葡萄糖组相比,0.9%的NaCl组在24小时和48小时内尿量显著增加 (9500毫升 vs. 7395毫升,p=0.001) 和尿量增加 (p<0.05).
- 在NaCl组中,需要较低的累积富罗塞米德剂量 (220毫克对280毫克,p=0.02).
- 的分量分泌在NaCl组中较高 (19.0%对14.7%,p=0.030),表明近端管状再吸收受阻,相对远端再吸收较低 (86.9%对91.5%,p<0.001).
结论:
- 与葡萄糖相比,0.9% NaCl的输液显著增强了急性心力衰竭患者在利尿剂治疗中的利尿和自然利尿.
- 这种改善的脱塞与循环利尿剂需求的减少有关,这可能是由于近端管道内再吸收受阻和较低的热度.
- 这些发现挑战了在AHF的脱凝过程中严格限制/的必要性.
相关概念视频
01:30Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
01:22Heart Failure Drugs: Diuretics
812
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
812
01:22Heart Failure VI: Adjunct Therapies
263
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
263
01:29Heart Failure II: Pathophysiology
752
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
752
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
943
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
943
01:30Heart Failure VII: Nursing Interventions
425
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
425